Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/94369
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | The optimal use of PEG-Asparaginase in relapsed ALL-Lessons from the ALLR3 clinical trial |
Author: | Masurekar, A. Fong, C. Hussein, A. Revesz, T. Hoogerbrugge, P. Love, S. Ciria, C. Parker, C. Krishnan, S. Saha, V. |
Citation: | Blood Cancer Journal, 2014; 4(4):e203-1-e203-3 |
Publisher: | Nature |
Issue Date: | 2014 |
ISSN: | 2044-5385 2044-5385 |
Statement of Responsibility: | A Masurekar, C Fong, A Hussain, T Revesz, PM Hoogerbrugge, S Love, C Ciria, C Parker, S Krishnan, and V Saha |
Keywords: | Humans Polyethylene Glycols Asparaginase Adolescent Child Female Male Precursor Cell Lymphoblastic Leukemia-Lymphoma |
Description: | letter to the editor |
Rights: | This work is licensed under a Creative Commons Attribution- NonCommercial-ShareAlike 3.0 Unported License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ |
DOI: | 10.1038/bcj.2014.26 |
Published version: | http://dx.doi.org/10.1038/bcj.2014.26 |
Appears in Collections: | Aurora harvest 7 Medicine publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
hdl_94369.pdf | Published version | 440.87 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.